当前位置:首页 > 关于我们 > 合作伙伴 > 杭州和达金融服务有限公司

杭州和达金融服务有限公司 | Hangzhou Heda Financial Services Co., Ltd.


杭州和达金融服务有限公司是区域性综合产业金融服务平台,为区域内生物医药、先进制造、数字信息等新兴产业提供母基金管理、直投基金管理、融资租赁、FA财顾等产业金融服务,为创新产业发展营造资本生态链。
公司管理的杭州和达产业基金投资有限公司(以下简称产业母基金),重点选择行业垂直领域国内外知名投资机构合作共同出资设立了27个子基金,总规模180亿元,已投项目168个,包括荣昌制药、奥泰生物、奇安信、奥精医疗等知名上市企业。
由公司下属私募股权投资基金管理人杭州和达投资管理有限公司于2018年发起设立的和达生物医药产业基金共三期,总规模10亿元,已投包括多禧生物、明峰医疗、天境生物、索元生物、卓健科技、联川生物、百力司康、海昶生物、凌科药业、葆元生物等17个项目,近一半被列入2020杭州准独角兽榜单。公司于2021年继生物医药直投基金后发起设立创芯成长基金,主要投向除生物医药外的创新产业,已投项目包括中欣晶圆、圣禹新材等。
Hangzhou Heda Financial Services Co., Ltd. is a regional comprehensive industrial financial service platform, which provides industrial financial services such as master fund management, direct investment fund management, financial leasing and FA financial consulting for emerging industries,like biomedicine, advanced manufacturing and digital information, and creates a capital ecological chain for the development of innovative industries.
Hangzhou Heda Industrial Fund Investment Co., Ltd. (hereinafter referred to as the industrial master Fund) managed by the company focuses on the vertical fields of the industry, cooperates with well-known investment institutions at home and abroad, jointly funded and established 27 sub funds with a total scale of 18 billion yuan, and has invested 168 projects, including well-known listed enterprises such as Rongchang pharmaceutical, Hangzhou Alltest Biotech, QI-ANXIN and Allgens medical.
Hangzhou Heda Investment Management Co., Ltd. initiated and established three phases of Heda biomedical industry fund in 2018, with a total scale of 1 billion yuan. It has invested 17 projects, including Hangzhou DAC biotechnology, Minfound medical, I-Mab Biopharma, Denovo Biopharma, Zhuojian technology, Lianchuan biology, bailiskang, Haichang biotech, Lynk Pharmaceuticals and AnHeart Therapeutics, Nearly half of them were included in the list of quasi unicorns in Hangzhou in 2020. In 2021, following the direct investment fund of biomedicine, the company initiated the establishment of Chuangxin growth fund, which mainly invests in innovative industries other than biomedicine. The invested projects include Ferrotec, Shengyu new materials, etc.

0.173248s